Advertisement
European health systems are requiring an increase in cost-sharing measures for patients 50 years of age and older

European Countries Implementing Cost-Sharing

0
Some financial protections are in place for poorer populations
In order to remind adults of the importance of immunizations throughout life

August Designated National Immunization Awareness Month

0
Resources available to up immunization include webinars and videos, training program for residents
Recurrent diabetic ketoacidosis is common

About One in Five Have Recurrent Diabetic Ketoacidosis

0
Patients with four or more DKAs accounted for 26.3 percent of encounters, 5.8 percent of total DKA group
For patients in the Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation trial

Usual Apixaban Dosing OK With One Dose-Reduction Criterion

0
5 mg apixaban twice daily deemed safe, appropriate for those with one criterion in ARISTOTLE trial
For women with newly diagnosed breast cancer

Online Communication Tied to Positive Appraisal of Tx Decisions

0
More frequent online users more positively appraise their decision making in breast cancer
Eczema have a serious impact on patients' quality of life and overall health

Eczema’s Effect on Patient Health Can Be Extensive

0
Patients diagnosed with eczema may have increased risk for other conditions as well
For patients with metastatic melanoma

Add-On Local Peripheral Tx Beneficial in Metastatic Melanoma

0
Addition to ipilimumab has beneficial effect on overall survival even after adjustment
Adlyxin (lixisenatide)

FDA Approves Adlyxin for Type 2 Diabetes Mellitus

0
Once-daily injection to improve glycemic control, along with diet and exercise
The seasonal influenza vaccine may significantly reduce mortality for patients with type 2 diabetes

Flu Vaccine Protective Against Hospitalization, Death in T2DM

0
Significantly lower rates of admission for stroke, heart failure, pneumonia/influenza, all-cause-death
The U.S. Food and Drug Administration announced Tuesday that it's strengthening label warnings on fluoroquinolones because the drugs can lead to disabling side effects

FDA Strengthens Safety Warnings for Fluoroquinolones

0
Fluoroquinolones such as Cipro, Levaquin should be reserved for life-threatening infections